Indianapolis Business Journal

JANUARY 14-20, 2011

This week, see what new tactic the national American Legion is using to shore up its bottom line and find out what effect repeated price cuts had on Endocyte's initial IPO. In Focus, find out how city boosters are looking to supplement local convention business. And in Forefront, columnists weigh in on topics such as  social discourse, taxes, grading teachers, political conventions and the North of South development.

Front PageBack to Top

Aspiring filmmaker scores hit with jewelry ad

A TV commercial for jeweler Reis-Nichols has launched filmmakers Sami Mustaklem and Alex Kosene into the advertising business. Their firm, 3rd Strand, has a growing list of clients seeking their unique storytelling approach.

Read More

Top StoriesBack to Top

Budget shrinks 21st Century tech fund

Even as some of its investments bear fruit in grand fashion, the state’s principal fund for investing in high-tech companies may get even less in the next budget than it did two years ago when its funding was cut in half.

Read More

Marketing entrepreneur’s career takes healthy turn

A rejuvenating massage and facial were the inspiration for Jennifer Rubenstein to found Simply Well LLC, a marketing business that launched the Simply Well Book in September. The book features offers from 46 locally owned salons, organic markets, yoga studios and similar businesses.

Read More

FocusBack to Top

OpinionBack to Top

WellPoint exec’s complaint is ironic

A survey last year by the Center for American Progress Action Fund found that double-digit hikes were implemented or were pending in at least 11 other states among the 14 where WellPoint’s Blue Cross Blue Shield companies are active.

Read More

Brokers work as difference-makers

Our industry is poised to change, but you missed what’s happening not only in our firm every day, but with our peers in the field that have long since fought against the natural trends of our industry in order to provide value and create solid outcomes—to be difference-makers.

Read More

In BriefBack to Top

Recent successes don’t change Lilly’s outlook

Eli Lilly and Co. can be credited with using acquisitions to unclog its product pipeline. It launched two drugs in the past 18 months, won market approval for a third and will likely get nods for two more drugs this year. Trouble is, they all have paltry sales prospects.

Read More